Bailey Fisher works with Horizon Discovery on Operations Director search

Bailey Fisher Executive Search is pleased to be working with Horizon Discovery Group plc, the Cambridge-based life science company supplying research tools to organisations tailoring personalised medicines for patients’ genetic make-up.

Following a highly successful AIM IPO, in which it raised £40m, Horizon Discovery is broadening its product portfolio and service offering, as well as expanding its global operations.  Horizon Discovery is looking to appoint an experienced Operations Director to make a significant contribution to the delivery of the company’s growth.

The right individual will require experience within IT, shipping/supply chain logistics and facilities, coupled with in-depth knowledge of the life science market. The individual will be required to commit to a long term programme of growth, and have the execution capability to see it through. They will need to be a life scientist, with intelligence and outstanding inter-personal skills. Culturally, the ethos of Horizon suits ambitious, commercially driven individuals who are dedicated to delivering outstanding customer service. Innovative people thrive here.

Horizon is a revenue-generating life science company supplying research tools to organizations engaged in genomics research and the development of personalized medicines. Horizon has a diverse and international customer base approaching 800 organizations, including major pharmaceutical, biotechnology and diagnostic companies as well as leading academic research centres. The Company supplies its products and services into multiple markets, estimated to total in excess of £29 billion by 2015.

Horizon’s core capabilities are built around its proprietary translational genomics platform, GENESIS™, a high-precision and flexible suite of gene editing tools. Horizon has applied GENESIS™ to create over 550 X-MAN™ cell lines, accurately modelling the disease-causing mutations found in genetically based diseases. These ‘patients-in-a-test-tube’ are being used by customers to identify the effect of individual or compound genetic mutations on drug activity, patient responsiveness, and resistance, which may lead to the successful prediction of which patient sub-groups will respond to
currently-available and future drug treatments.

Bailey Fisher Executive Search has been retained by Horizon Discovery to manage the search. The search is being run by Claire Button, who heads up the Life Sciences Practice at Bailey Fisher, working with a broad base of clients from early stage VC funded companies through privately owned SMEs to large corporates.  Claire has a PhD in Immunopharmacology.

*******

Bailey Fisher Executive Search is an independent executive search firm specialising in the technology sector.  The company operates internationally from offices in Cambridge and London. www.baileyfisher.com

_________________________________________



Read more

Looking for something specific?